Key Takeaways

  • Clonidine can reduce physical withdrawal symptoms linked to an overactive nervous system, including sweating, anxiety, agitation, restlessness, rapid heartbeat, high blood pressure, chills, stomach cramps, nausea, diarrhea and sleep problems (Yasaei et al., 2023; ASAM, 2020a) (NCBI).

  • Clonidine is most often used off-label for opioid withdrawal, where alpha-2 adrenergic agonists can ease withdrawal discomfort; however, buprenorphine and methadone are generally more effective for opioid withdrawal management and can also treat cravings and opioid use disorder (ASAM, 2020a) (Lippincott Journals).

  • Clonidine is not a complete addiction treatment. It may support detox by easing symptoms, but ongoing care may still be needed, including medication-assisted treatment, therapy, relapse prevention and recovery support (ASAM, 2020a; SAMHSA, 2021) (Lippincott Journals).

  • For alcohol withdrawal, clonidine should only be used as an add-on medication. It may help control anxiety, sweating, rapid heartbeat and high blood pressure, but it does not prevent seizures or delirium tremens; benzodiazepines remain first-line treatment for moderate to severe alcohol withdrawal (ASAM, 2020b; Tiglao et al., 2021) (ASAM, 2020a).

    Free, Confidential Helpline

    Ready to take the next step toward recovery?

    Our Recovery Advocates are available around the clock to answer your questions, verify your insurance, and help you find the right level of care — at no cost to you.

    Call Us Now

    (561) 340-7269

    Available 24 hours a day, 7 days a week

  • For benzodiazepine withdrawal, clonidine does not replace a supervised taper. Rapid dose reductions or abruptly stopping benzodiazepines can cause serious, potentially life-threatening withdrawal, including seizure risk (ASAM, 2025) (ASAM Downloads).

  • Clonidine can cause side effects that require monitoring, including dizziness, drowsiness, dry mouth, constipation, fatigue, low blood pressure, slow heart rate, sedation and weakness; people with heart, blood pressure or kidney concerns may need extra caution (Yasaei et al., 2023) (NCBI).

  • Clonidine should not be stopped suddenly. Abrupt discontinuation can cause rebound high blood pressure and may trigger anxiety, agitation, headache, rapid heartbeat or nervousness, so dose changes should be medically supervised (Yasaei et al., 2023) (NCBI).

  • Clonidine and lofexidine are related but not identical. Both are alpha-2 adrenergic agonists used for opioid withdrawal symptoms, but lofexidine is FDA-approved for opioid withdrawal in adults, while clonidine is commonly used off-label (FDA, 2018) (FDA Access Data).

  • Medical detox may be safer when withdrawal symptoms are severe or high-risk, including confusion, hallucinations, severe anxiety, dehydration, uncontrolled vomiting or diarrhea, very high blood pressure, rapid heartbeat, seizure history, severe insomnia, strong cravings or thoughts of self-harm (ASAM, 2020a; ASAM, 2020b) (Lippincott Journals).

 

Clonidine is a prescription medication that may be used to help ease certain physical withdrawal symptoms. It is most often discussed for opioid-related discomfort, but it may also be considered in some alcohol or drug detox plans when medically appropriate. It is FDA-approved for conditions such as high blood pressure, and its use for opioid-related care is considered off-label (American Society of Addiction Medicine [ASAM], 2020a; Yasaei et al., 2023).  Clinical studies have also supported its efficacy, particularly in opioid withdrawal, making it a valuable tool in addiction treatment protocols. 

Stopping or reducing substance use can place the body in a heightened stress state. This can lead to sweating, anxiety, restlessness, tremors, rapid heartbeat, elevated blood pressure, chills, stomach cramps and trouble sleeping. This medication may help reduce some of these effects by calming activity in the nervous system. Alpha-2 adrenergic agonists, including this medication and lofexidine, have been shown to reduce the severity of opioid withdrawal symptoms compared with placebo (Centers for Disease Control and Prevention [CDC], 2022).

This medicine is not a cure for addiction, and it does not treat every concern linked to substance use. It does not fully stop cravings, prevent all medical risks or replace supervised care. Because it can lower blood pressure and slow heart rate, it should only be used under medical supervision (Yasaei et al., 2023).

Quick Answer: How Can Clonidine Manage Withdrawal Symptoms?

Clonidine helps reduce some withdrawal symptoms caused by an overactive nervous system.

When someone stops using opioids, alcohol or certain other substances, the body may react with a surge of stress-related activity. This reaction can cause sweating, anxiety, shaking, restlessness, a racing heart and elevated blood pressure.

Clonidine works by reducing sympathetic nervous system activity and lowering norepinephrine release, which helps calm the body’s “fight or flight” response (Yasaei et al., 2023). By lowering this stress response, it may make certain detox symptoms feel less intense. ASAM notes that alpha-2 adrenergic agonists, including off-label clonidine and FDA-approved lofexidine, can be safe and effective for opioid-related discomfort when used appropriately (ASAM, 2020a).

For further information on clonidine’s role in opioid withdrawal, the National Institutes of Health provides a comprehensive overview of its usage and efficacy.

Key Facts About This Detox Medication

Question

Answer

What is it?

A prescription medication commonly used for high blood pressure and sometimes used off-label for detox-related discomfort

What can it help?

Sweating, anxiety, agitation, rapid heartbeat, high blood pressure, tremors, chills, stomach cramps, nausea, diarrhea and restlessness

Is it used for opioid care?

Yes, it is commonly used off-label to help with certain opioid-related physical effects

Does it stop cravings?

No, it does not directly treat cravings the way buprenorphine or methadone can

Is it addictive?

It is not an opioid, but stopping it suddenly can cause rebound effects

Can it be used alone?

Usually no. It is often one part of a broader medical plan

Does it help with alcohol-related concerns?

It may help some physical effects, but it is not a first-line alcohol medication and does not prevent seizures

Do you need a prescription?

Yes. It should only be taken under medical guidance

Symptoms It May Ease During Detox

This medication may help reduce physical effects linked to nervous system overactivity. These are often the signs that make early recovery feel physically overwhelming.

It may help with:

  • Anxiety
  • Agitation
  • Restlessness
  • Sweating
  • Chills or hot flashes
  • Rapid heartbeat
  • Elevated blood pressure
  • Tremors
  • Runny nose
  • Watery eyes
  • Abdominal cramps
  • Nausea
  • Vomiting
  • Diarrhea
  • Trouble sleeping

Clinical reviews describe alpha-2 adrenergic agonists as useful for autonomic opioid withdrawal symptoms, such as sweating, rapid heart rate, restlessness and gastrointestinal discomfort, though they do not address every concern or replace medications for opioid use disorder (Srivastava et al., 2020).

This medication may make the process more manageable, but it does not remove all discomfort. Some people may still need fluids, sleep support, monitoring, other medications or a higher level of care.

What This Medication Does Not Treat

Clonidine has limits. It may reduce some physical discomfort, but it does not treat the full medical, emotional or behavioral impact of substance use.

It does not:

  • Cure addiction
  • Fully stop opioid cravings
  • Prevent relapse on its own
  • Treat the underlying causes of drug or alcohol use
  • Prevent alcohol-related seizures
  • Prevent benzodiazepine withdrawal seizures
  • Replace therapy, rehab or medication-assisted treatment
  • Work safely for everyone

This is why it is usually used as part of a larger treatment plan. ASAM emphasizes that getting through acute withdrawal alone is not the same as treating opioid use disorder; ongoing evidence-based care is needed to support recovery and reduce relapse risk (ASAM, 2020a).

Opiate Withdrawal Symptoms: Where It May Help

Clonidine is often used for opioid-related physical discomfort. Opioids include substances such as heroin, fentanyl, oxycodone, hydrocodone, morphine and methadone.

Opiate withdrawal can include sweating, chills, body aches, nausea, vomiting, diarrhea, stomach cramps, anxiety, insomnia, yawning, runny nose, watery eyes and goosebumps (Srivastava et al., 2020).

Clonidine can help reduce many of these effects by calming the overactive nervous system. It is considered a non-opioid medication because it does not activate opioid receptors in the brain.

This can make it helpful for people who need physical symptom relief during opioid detox. However, it is not the same as buprenorphine or methadone. Those medications can reduce discomfort and cravings by acting on opioid receptors. This medicine mainly helps with certain physical effects. Current literature identifies buprenorphine and methadone as core evidence-based medications for opioid use disorder, while alpha-2 adrenergic agonists may help when clinically appropriate (Srivastava et al., 2020).

Does It Help With Opioid Cravings?

This medicine does not directly stop cravings.

It may reduce physical discomfort, anxiety or agitation that can make cravings feel worse. However, it does not treat opioid use disorder in the same way as medications such as buprenorphine or methadone. Buprenorphine, methadone and naltrexone are FDA-approved medications for opioid use disorder, while clonidine is not an FDA-approved treatment for opioid use disorder itself (Substance Abuse and Mental Health Services Administration [SAMHSA], 2021).

For this reason, it may be used alongside other treatment approaches. A medical provider can determine whether clonidine, buprenorphine, methadone, lofexidine, naltrexone or another option is appropriate.

How Long Do Opioid Detox Symptoms Last?

The timeline depends on the type of opioid used, how long a person used it, how much they used and their overall health.

Short-acting opioids may cause discomfort within several hours after the last use. It often peaks within the first few days and improves over several days. Longer-acting opioids may have a later onset and a longer symptom period (Srivastava et al., 2020).

Clonidine may reduce intensity during this process, but it does not guarantee a shorter timeline. In medical detox, providers can monitor progress and adjust care as needs change.

How This Medication Is Taken During Detox

Clonidine may be given as a tablet or a patch. The right form depends on a person’s condition, medical history, vital signs and care setting. It is available in oral and transdermal formulations, and both forms can affect blood pressure and heart rate (Yasaei et al., 2023).

Tablets

Tablets are taken by mouth. During care, a provider may adjust the timing and dose based on physical signs, blood pressure and heart rate.

Because the medication can lower blood pressure, vital signs may need to be checked before or during dosing. Patients should not adjust their medication schedule or take extra medication without medical guidance.

Patch

A patch is placed on the skin and releases medication slowly over time. This may provide steadier medication delivery.

Patch strength, timing and removal should always be managed by medical staff.

Safety Considerations and Side Effects

This medication can be safe when prescribed and monitored by a medical professional. However, it is not safe for everyone.

Possible side effects include:

  • Dizziness
  • Drowsiness
  • Fatigue
  • Dry mouth
  • Headache
  • Constipation
  • Nausea
  • Weakness
  • Low blood pressure
  • Slow heart rate
  • Sedation

Known adverse effects include hypotension, bradycardia, dizziness, sedation, fatigue, constipation and dry mouth (Yasaei et al., 2023). More serious risks can include fainting, irregular heartbeat, dangerously low blood pressure or rebound high blood pressure if it is stopped suddenly. Because of these risks, clinical guidance recommends that medications be selected based on medical history, symptom severity and care setting (ASAM, 2020a).

People with heart conditions, low blood pressure, kidney disease, a history of fainting or multiple prescription medications may need extra monitoring or a different medication.

Can You Stop It Suddenly?

Clonidine should not be stopped suddenly unless a healthcare provider says to do so.

Stopping it abruptly can cause rebound high blood pressure. It may also lead to anxiety, agitation, headache, rapid heartbeat or nervousness. Rebound hypertension is a known risk of abrupt discontinuation, which is why tapering may be needed when stopping the medication (Yasaei et al., 2023).

If it needs to be stopped, a provider may recommend lowering it gradually.

Medication Interactions to Know

Clonidine may interact with other medications or substances. Before taking it, tell your provider about all prescription medications, over-the-counter medications, supplements and substances you use.

It may interact with:

  • Blood pressure medications
  • Heart medications
  • Sedatives
  • Sleep medications
  • Anxiety medications
  • Antidepressants
  • Seizure medications
  • Alcohol
  • Other substances that cause drowsiness or lower blood pressure

Taking it with other sedating substances can increase the risk of dizziness, falls, low blood pressure or excessive sedation. It should be used carefully with other medications that lower blood pressure, slow heart rate or depress the central nervous system (Yasaei et al., 2023).

Clonidine vs. Other Detox Medications

Clonidine is one of several medications that may be used during detox. The best option depends on the substance involved, symptom severity, medical history and treatment goals.

Compared With Lofexidine

Clonidine and lofexidine are both alpha-2 adrenergic agonists. Both can help reduce certain opioid detox symptoms by calming nervous system activity.

The major difference is that lofexidine is FDA-approved specifically for opioid withdrawal, while clonidine is commonly used off-label. The FDA approved lofexidine in 2018 for reducing opioid-related physical discomfort during abrupt discontinuation in adults (FDA, 2018; Urits et al., 2020).

A provider can help determine which option is appropriate based on symptoms, side effects, cost, availability and medical history.

Compared With Buprenorphine

Buprenorphine is a partial opioid agonist. It acts on opioid receptors to reduce physical discomfort and cravings.

Clonidine is not an opioid and does not act on opioid receptors. It may help with physical effects like sweating, anxiety and rapid heartbeat, but it does not reduce cravings in the same way buprenorphine can. SAMHSA identifies buprenorphine as one of the FDA-approved medications for opioid use disorder (SAMHSA, 2021).

Compared With Methadone

Methadone is a long-acting opioid medication that can reduce physical discomfort and cravings. It is often used in structured opioid treatment programs.

Clonidine may help with certain physical effects, but it does not provide the same opioid receptor support or craving control as methadone. SAMHSA identifies methadone as an FDA-approved medication for opioid use disorder that must be dispensed through certified opioid treatment programs (SAMHSA, 2021).

Compared With Naltrexone

Naltrexone is an opioid blocker. It is not used to ease active opioid detox symptoms and should only be started after opioids are cleared from the body.

Starting naltrexone too soon can trigger sudden withdrawal. Clonidine may be used earlier in detox to help manage withdrawal symptoms, depending on medical guidance. Naltrexone is FDA-approved for opioid use disorder, but patients must be opioid-free before starting it to avoid precipitated withdrawal (SAMHSA, 2021).

Alcohol Detox Considerations

Clonidine may help with some alcohol detox symptoms, especially effects related to nervous system overactivity. These can include sweating, anxiety, elevated blood pressure and rapid heartbeat.

However, clonidine is not a first-line treatment for alcohol withdrawal. Alcohol detox can be dangerous and may cause seizures, hallucinations or delirium tremens. Clonidine does not prevent these serious complications.

Benzodiazepine-type sedatives are commonly used for moderate to severe withdrawal because they help reduce the risk of seizures and delirium tremens. ASAM’s alcohol guideline states that alpha-2 adrenergic agonists such as clonidine may be used as adjuncts to these sedatives for autonomic hyperactivity and anxiety, but they should not be used alone to prevent or treat seizures or delirium (ASAM, 2020b).

People who drink heavily, have a history of severe withdrawal or have ever had seizures after stopping alcohol should seek medical help before stopping use.

Benzodiazepine Detox Considerations

Clonidine may help with certain sedative-related effects, such as anxiety, sweating, agitation or elevated blood pressure. However, it is not the primary treatment for this type of care.

Common prescription sedatives include Xanax, Klonopin, Ativan and Valium. Stopping these medications suddenly can cause severe anxiety, insomnia, tremors, confusion and seizures. ASAM’s tapering guideline states that abrupt discontinuation or rapid reduction can lead to serious and potentially life-threatening withdrawal symptoms (ASAM, 2025).

Clonidine does not prevent seizure risk in this setting. The safest approach usually involves a medically supervised taper. Anyone who has been taking these medications regularly should speak with a provider before reducing or stopping use.

Can You Detox at Home?

Some people may be prescribed clonidine in an outpatient setting, but home detox is not safe for everyone. Symptoms can become unpredictable, especially with alcohol, opioids, sedatives or multiple substances.

Medical detox may be safer if you:

  • Use opioids, alcohol, sedatives or multiple substances
  • Have a history of seizures
  • Have had severe symptoms before
  • Have relapsed after trying to quit
  • Have heart problems, low blood pressure or other medical conditions
  • Have anxiety, depression, trauma or suicidal thoughts
  • Are unsure what substances are in your system
  • Need 24/7 medical monitoring

In a supervised program, staff can monitor symptoms, check vital signs, adjust medications and help reduce complications. Clinical guidelines emphasize matching care to medical risks, symptom severity and treatment setting (ASAM, 2020a; ASAM, 2020b).

When To Seek Medical Detox

Medical detox may be recommended when symptoms are difficult to manage, medically risky or likely to lead to relapse.

You should consider medical support if you are experiencing:

  • Shaking or tremors
  • Severe anxiety or panic
  • Vomiting or diarrhea
  • Dehydration
  • High blood pressure
  • Rapid heartbeat
  • Confusion
  • Hallucinations
  • Severe insomnia
  • Strong cravings
  • A history of withdrawal seizures
  • Thoughts of self-harm

If symptoms feel severe or life-threatening, call 911 or seek emergency care. ASAM’s alcohol guideline notes that alcohol-related withdrawal syndrome can involve severe complications, including seizures and delirium, requiring appropriate medical treatment (ASAM, 2020b).

What Happens After Detox?

Detox is the first step, not the full recovery process. Clonidine may help reduce symptoms, but ongoing treatment helps address the reasons substance use developed and continued.

After detox, treatment may include:

  • Inpatient rehab
  • Partial hospitalization programming
  • Intensive outpatient treatment
  • Medication-assisted treatment
  • Individual therapy
  • Group therapy
  • Dual diagnosis care
  • Relapse prevention planning
  • Family support
  • Aftercare planning

The goal is not only to get through detox but to build a stable plan for long-term recovery. Clinical guidelines for opioid use disorder emphasize that dependence withdrawal is not sufficient care by itself and should be followed by ongoing treatment, including medications for opioid use disorder when appropriate (ASAM, 2020a; SAMHSA, 2021).

Drug Detox and Addiction Treatment in Lake Worth, Florida

The Recovery Village Palm Beach at Baptist Health provides medically supervised detox and addiction treatment in Lake Worth, Florida. Our team helps patients manage symptoms safely and transition into the next level of care based on their needs.

Treatment may include medical detox, inpatient care, medication-assisted treatment, dual diagnosis care, therapy and aftercare planning. If clonidine or another medication is appropriate, it may be used as part of a personalized plan.

Our Recovery Advocates are available 24/7 to answer your questions, verify insurance and help you understand your treatment options.

Recovering From Drug or Alcohol Addiction

If you are struggling with a drug or alcohol addiction, it might be time for professional treatment. The experts at The Recovery Village Palm Beach at Baptist Health are able to identify and treat substance use disorders as well as other co-occurring mental health conditions. Contact us today to learn more about treatment programs that can work well for you.

FAQ

Can this medication help with detox symptoms?

Yes. Clonidine may help reduce certain symptoms, especially those caused by an overactive nervous system. These may include sweating, anxiety, agitation, tremors, rapid heartbeat and elevated blood pressure (ASAM, 2020a; Srivastava et al., 2020).

Is it used for opioid detox?

Yes. Clonidine is commonly used off-label to help with opioid detox symptoms. It may help with physical discomfort but does not directly treat cravings (ASAM, 2020a; Srivastava et al., 2020).

What opioid symptoms can it help with?

Clonidine may help with sweating, chills, anxiety, agitation, restlessness, tremors, stomach cramps, nausea, vomiting, diarrhea, runny nose, watery eyes and elevated heart rate (Srivastava et al., 2020).

Does it stop cravings?

No. Clonidine does not directly stop cravings. Other medications, such as buprenorphine or methadone, may be used to help reduce cravings (SAMHSA, 2021).

Is it addictive?

Clonidine is not an opioid and is not considered addictive in the same way opioids or sedatives can be. However, stopping it suddenly can cause rebound hypertension, so it should only be stopped under medical guidance (Yasaei et al., 2023).

Can it be used for alcohol detox?

Clonidine may help with certain alcohol detox symptoms, such as high blood pressure, anxiety or rapid heart rate. It should not be used alone to treat this process because it does not prevent seizures or delirium tremens (ASAM, 2020b).

Can it be used for benzodiazepine detox?

Clonidine may help with some physical effects, but it does not prevent sedative-related seizures. This type of detox should be managed by a medical professional, usually through a gradual taper when appropriate (ASAM, 2025).

Is it FDA-approved for detox?

Clonidine is FDA-approved for certain conditions, such as high blood pressure, but it is commonly used off-label for detox symptoms. Lofexidine is FDA-approved specifically for opioid withdrawal (ASAM, 2020a; FDA, 2018).

What are the side effects?

Common side effects may include dizziness, drowsiness, dry mouth, fatigue, constipation, headache, low blood pressure and slow heart rate (Yasaei et al., 2023).

Can I take it at home?

Only take clonidine if it is prescribed by a healthcare provider. Home detox may not be safe for everyone, especially people detoxing from alcohol, opioids, sedatives or multiple substances.

Is it enough for detox?

Usually, no. Clonidine may help reduce certain symptoms, but detox often requires medical monitoring, supportive care, other medications and follow-up treatment (ASAM, 2020a; SAMHSA, 2021).

References

American Society of Addiction Medicine. (2020a). The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update. Journal of Addiction Medicine, 14(2S), 1–91.
https://downloads.asam.org/sitefinity-production-blobs/docs/default-source/guidelines/npg_2020_focus_update-final.pdf

American Society of Addiction Medicine. (2020b). The ASAM clinical practice guideline on alcohol withdrawal management. Journal of Addiction Medicine, 14(3S), 1–72.
https://downloads.asam.org/sitefinity-production-blobs/docs/default-source/quality-science/the_asam_clinical_practice_guideline_on_alcohol-1.pdf

American Society of Addiction Medicine. (2025). Joint clinical practice guideline on benzodiazepine tapering: Considerations when risks outweigh benefits.
https://downloads.asam.org/sitefinity-production-blobs/docs/default-source/guidelines/benzodiazepine-tapering-2025/bzd-tapering-document—final-approved-version-for-distribution-02-28-25.pdf

Centers for Disease Control and Prevention. (2022). CDC clinical practice guideline for prescribing opioids for pain — United States, 2022. MMWR Recommendations and Reports, 71(3), 1–95.
https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm

Substance Abuse and Mental Health Services Administration. (2021). Medications for opioid use disorder (Treatment Improvement Protocol Series 63).
https://www.ncbi.nlm.nih.gov/books/NBK574910/

Srivastava, A. B., Mariani, J. J., & Levin, F. R. (2020). New directions in the treatment of opioid withdrawal. The Lancet, 395(10241), 1938–1948.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7385662/

Tiglao, S. M., Meisenheimer, E. S., & Oh, R. C. (2021). Alcohol withdrawal syndrome: Outpatient management. American Family Physician, 104(3), 253–262.
https://www.aafp.org/pubs/afp/issues/2021/0900/p253.html

Urits, I., Patel, M., Putz, M. E., Monteferrante, N. R., Nguyen, D., An, D., Kaye, A. D., Viswanath, O., & Kaye, R. J. (2020). A comprehensive update of lofexidine for the management of opioid withdrawal symptoms. Psychopharmacology Bulletin, 50(3), 76–96.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7377538/

U.S. Food and Drug Administration. (2018). Lucemyra approval package: Multidiscipline review.
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/209229Orig1s000MultidisciplineR.pdf

Yasaei, R., Saadabadi, A., & Barboza, J. N. (2023). Clonidine. In StatPearls. StatPearls Publishing.
https://www.ncbi.nlm.nih.gov/books/NBK459124/